drugset / Trial / NCT06913595

Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery

NCT06913595

Phase 1 Active not recruiting 100 enrolled Cairo University
RandomizedParallel-groupSingle-blindPrevention

Summary

Extended Venous Thromboemboism Prophylaxis After Bariatric Surgeries: A Comparison Of Low Molecular Weight Heparin With Direct Oral Anticoagulant

Timeline

Start
2024-03-25
Primary completion
2025-10-25
Completion
2025-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enoxaparin sodium Other / unclassified
Subject Rivaroxaban Other / unclassified